AR and neoplasm: Because many PARPi can induce PARP trapping, resulting in the formation of dsDNA lesions207, and anti-AR therapies have been demonstrated to result in a delay in dsDNA break repair in the presence of DNA damage, combining these therapies may be effective in creating deleterious lesions for tumor cells.